Related Experiment Videos
Towards a research agenda for pharmaceutical issues.
1Corporate Strategic Planning and Policy Division, Pfizer Inc, New York, N.Y., USA.
Pharmacoeconomics
|December 9, 1995
Summary
This study emphasizes the critical need for research into pharmaceutical cost containment in the US. It suggests analyzing expenditure trends and evaluating cost-containment systems for policy development.
Area of Science:
- Health Policy
- Pharmaceutical Economics
Background:
- The primary challenge in US pharmaceutical policy is cost containment.
- Understanding pharmaceutical expenditure trends, especially from the early 1990s, is crucial.
Purpose of the Study:
- To highlight the importance of research in pharmaceutical cost containment.
- To identify key areas for research, including expenditure analysis and cost-containment system evaluation.
Main Methods:
- Analysis of pharmaceutical expenditure trends.
- Examination of costs and returns in pharmaceutical development.
- Study of pharmaceutical cost-containment systems.
Main Results:
- Pharmaceutical cost containment is the most significant issue in US pharmaceutical policy.
- Research should focus on expenditure trends, development costs, and the impact of pharmaceuticals on system costs.
Conclusions:
- Further research into pharmaceutical expenditures and cost-containment strategies is essential for effective US health policy.
- Evaluating the impact of these systems on patients, drug diffusion, R&D, and international competitiveness is vital.